TY  - JOUR
T1  - PAtient preferences for deactivation of implantable cardioverter-defibrillators
AU  - Dodson JA, Fried TR, Van Ness PH, Goldstein NE, Lampert R
Y1  - 2013/03/11
N1  - 10.1001/jamainternmed.2013.1883
JO  - JAMA Internal Medicine
SP  - 377
EP  - 379
VL  - 173
IS  - 5
N2  - 
While implantable cardioverter-defibrillators (ICDs) prolong life, painful shocks can occur at the end of life, and physicians rarely discuss the option of device deactivation.1- 2 To prevent shocks at the end of life that do not meaningfully prolong survival, a recent Heart Rhythm Society consensus statement recommended proactive communication with patients regarding deactivation.3 However, most surveys have found that the majority of ICD patients would not consider deactivation even in deleterious future health states including terminal cancer,4 constant dyspnea,5 or frequent shocks.5- 6

SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.1883
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.1883
ER  -